CDRH Review Culture To Change As Consultant Use Becomes Routine – Feigal
This article was originally published in The Gray Sheet
Executive Summary
Nearly half of FDA's device center review staff likely will be relative newcomers as the agency heads into fiscal 2006, according to Center for Devices & Radiological Health Director David Feigal
You may also be interested in...
IVD Manufacturers, Labs Should Be Subject To Same Standards – AdvaMed
FDA should allow in vitro diagnostic manufacturers to partake of some of the same regulatory flexibility that clinical labs currently enjoy, AdvaMed suggests to HHS in 1Aug. 23 comments on stimulating medical technology innovation
IVD Manufacturers, Labs Should Be Subject To Same Standards – AdvaMed
FDA should allow in vitro diagnostic manufacturers to partake of some of the same regulatory flexibility that clinical labs currently enjoy, AdvaMed suggests to HHS in 1Aug. 23 comments on stimulating medical technology innovation
New Wave Of Hires May Precipitate CDRH Sea Change – Feigal
An infusion of "new blood" within the medical device regulatory community will provide an opportunity for substantial policy changes, outgoing CDRH Director David Feigal, MD/MPH, suggested April 16